|
Scoliosis brace
Scoliosis bracing and the
SpineCor Brace
Please be advised, the
Spinecorporation LTD manufactures
the Spinecor brace and only
recommends its use for Adolescent
Idiopathic Scoliosis. Any
other treatments or appropriate
therapy provided by our doctors is
in no way affiliated with the
Spinecorporation LTD.
Drs. Lamantia and Deutchman may
accept cases which do not meet the
inclusion criteria set forth by the
Spinecorporation LTD.
Abstract:
SpineCor - a non-rigid brace for the
treatment of idiopathic scoliosis:
post-treatment results (Euro Spine
2004) At 2 years follow-up
there was an overall correction of
greater than 5° for 55% of the
patients, 38% had a stabilization
and 7% had worsened by more than 5°.
This initial cohort of patients
demonstrated a general trend of
initial decrease in spinal curvature
in brace, followed by a correction
and/or stabilization at the end of
treatment, which was maintained
through 1, and 2 years' follow-up.
SpineCor is the first dynamic
flexible brace for the treatment of
idiopathic scoliosis. Although
the developers of SpineCor only
treat children, Scoliosis Systems
(TM), the largest provider of
SpineCor in the United States, has
designed protocols for the use of
the SpineCor brace with adults.
SpineCor Brace Survival Analysis of a Group of
365 Idiopathic Scoliosis Patients
(SRS 2005)
Charles H. Rivard M.D. et al.
|
Summary:
365 idiopathic
scoliosis patients
have been treated by
the SpineCor System.
They have been
categorized before
treatment into two
groups according to
their initial Cobb
angle, the first
having a curve from
15 to 29 degrees and
the other having a
curve of 30 degrees
and more. At five
years post weaning,
we achieved 96.2% of
success and 3.8% of
worsening.
Purpose:
The objective of
this study is to
show the
effectiveness of the
SpineCor system
dedicated to the
treatment of the
idiopathic
scoliosis.
Methods:
365 idiopathic
scoliosis patients
treated by the
SpineCor System was
followed at Sainte-
Justine Hospital.
The patients cohort
was categorized
before treatment
into two groups
according to their
initial Cobb angle:
group 1 (15 to 29
degrees) and group 2
(30 degrees and
more). A survival
analysis was carried
out in order to
evaluate the
cumulative
probability of
success during the
treatment, the
follow-up and for
the period combining
the treatment and
the follow-up.
Success was defined
as either
stabilization or a
reduction of 5º or
more of the initial
Cobb angle and
failure as a
worsening of more
than 5º.
Results:
The survival
analysis indicated a
cumulative
probability of
success that is
stable during the
post-treatment
follow-up period
(Year 1: 0.97, .093;
Year 2: 0.94, 0.88;
Year 3: 0.91, 0.84;
Year 4: 0.79, 0.84.
for the group 1 and
2 respectively).
There is an overall
probability of
success of 0.97 and
0.83 at 4 years;
0.85 and 0.61 at 7
years for group 1
and group 2
respectively of
combined treatment
and post treatment
follow-up. At five
years post weaning
there was a
permanent correction
for 65.4% of the
patients, 30.8% had
a stabilization and
3.8% had worsened.
Conclusion:
Because of the
progressive
reduction of the
pathological
defects, owing to
the fact that
SpineCor system does
not offer any effect
of distraction or
support and of
maintains of an
effective
musculature, there
is only one very
small percentage
(3.8 %) of loss of
correction 5 years
after the end of
bracing.
Significance:
The conservative
treatment with
SpineCor brace in
A.I.S. is efficient.
|
|
|
